Volume 11, Issue 3 (5-2020)                   Caspian J Intern Med 2020, 11(3): 310-314 | Back to browse issues page


XML Print


Download citation:
BibTeX | RIS | EndNote | Medlars | ProCite | Reference Manager | RefWorks
Send citation to:

Faramarzi E, Jaberi N, Farahbakhsh M, Ostadrahimi A, Asghari Jafarabadi M, Fakhari A. Prevalence of metabolic syndrome in schizophrenia patients treated with antipsychotic medication. Caspian J Intern Med 2020; 11 (3) :310-314
URL: http://caspjim.com/article-1-2035-en.html
Liver and Gastrointestinal Diseases Research center, Tabriz University of Medical sciences,Tabriz, Iran , elnazfaramarzi849@gmail.com
Abstract:   (3884 Views)
Background: This study was conducted to determine the prevalence of metabolic syndrome (Mets) in schizophrenic patients in a 6-month period of treatment with antipsychotic medications.
Methods: In this study, 60 volunteer schizophrenic patients were included. At the onset and 6 months after treatment with antipsychotic medications, fasting blood sugar (FBS), serum triglyceride (TG), high density lipoprotein (HDL), weight, waist circumference (WC), and blood pressure were determined. We defined Mets according to ATPIII criteria.
Results: After a 6-month treatment with antipsychotic drugs, the mean WC, serum TG, HDL, systolic and diastolic blood pressure increased but the changes of WC and HDL were statistically significant (p<0.05). We found that the percentage of patients with high WC, low HDL levels, and Mets increased after treatment which was statistically significant (p<0.05).
Conclusion: It is recommended that nutritional and lifestyle changes intervention should be implanted for schizophrenic patients undergoing treatment.
Full-Text [PDF 200 kb]   (1079 Downloads)    
Type of Study: Original Article | Subject: psychiatry
Received: 2019/08/27 | Accepted: 2020/02/3 | Published: 2020/05/21

Add your comments about this article : Your username or Email:
CAPTCHA

Send email to the article author


Rights and permissions
Creative Commons License This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License.

© 2024 CC BY-NC 4.0 | Caspian Journal of Internal Medicine

Designed & Developed by: Yektaweb